Amanda Sheets

482 total citations · 1 hit paper
19 papers, 282 citations indexed

About

Amanda Sheets is a scholar working on Epidemiology, Pharmacology and Microbiology. According to data from OpenAlex, Amanda Sheets has authored 19 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 6 papers in Pharmacology and 6 papers in Microbiology. Recurrent topics in Amanda Sheets's work include Pneumonia and Respiratory Infections (8 papers), Urinary Tract Infections Management (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Amanda Sheets is often cited by papers focused on Pneumonia and Respiratory Infections (8 papers), Urinary Tract Infections Management (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Amanda Sheets collaborates with scholars based in United States, United Kingdom and Germany. Amanda Sheets's co-authors include Joseph W. St. Geme, Peggy A. Cotter, Sandra P. McCurdy, Sue Cammarata, Jeffrey A. Melvin, Laura Lawrence, Erich V. Scheller, David Oldach, Gina M. Donato and Anita Das and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Journal of Bacteriology.

In The Last Decade

Amanda Sheets

18 papers receiving 274 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials

2024 44 citations Florian Wagenlehner, Caroline Perry et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amanda Sheets United States	9	158	90	70	54	47	19	282
Rosemol Varghese India	11	225 1.4×	85 0.9×	42 0.6×	71 1.3×	34 0.7×	25	352
Y. Yang China	14	323 2.0×	152 1.7×	104 1.5×	69 1.3×	25 0.5×	28	566
Charles Jakielaszek United States	8	86 0.5×	50 0.6×	122 1.7×	94 1.7×	58 1.2×	12	326
A Dickens United Kingdom	9	246 1.6×	47 0.5×	72 1.0×	106 2.0×	57 1.2×	11	364
Maria Labonia Italy	8	55 0.3×	54 0.6×	57 0.8×	145 2.7×	41 0.9×	11	252
Véronique Yvette Ntsogo Enguéné France	7	49 0.3×	61 0.7×	159 2.3×	217 4.0×	91 1.9×	10	337
Rolf Troller Switzerland	14	292 1.8×	109 1.2×	55 0.8×	117 2.2×	16 0.3×	17	442
Véronique Rieux France	10	193 1.2×	61 0.7×	37 0.5×	93 1.7×	96 2.0×	18	313
Makoto Niki Japan	11	126 0.8×	15 0.2×	81 1.2×	97 1.8×	16 0.3×	36	316
F. Chau France	14	190 1.2×	21 0.2×	78 1.1×	209 3.9×	111 2.4×	26	423

Countries citing papers authored by Amanda Sheets

Since Specialization

Citations

This map shows the geographic impact of Amanda Sheets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Sheets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Sheets more than expected).

Fields of papers citing papers by Amanda Sheets

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Sheets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Sheets. The network helps show where Amanda Sheets may publish in the future.

Co-authorship network of co-authors of Amanda Sheets

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Sheets. A scholar is included among the top collaborators of Amanda Sheets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Sheets. Amanda Sheets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Scangarella-Oman, Nicole E., John Breton, D. J. Brown, et al.. (2025). Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including drug-resistant phenotypes, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3). Antimicrobial Agents and Chemotherapy. 69(10). e0164024–e0164024. 1 indexed citations

Scangarella-Oman, Nicole E., et al.. (2025). Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including subsets with molecularly characterized resistance mechanisms and genotypes/epidemiological clones, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3). Antimicrobial Agents and Chemotherapy. 69(10). e0163924–e0163924.

Wagenlehner, Flo ri an, Caroline Perry, Thomas M. Hooton, et al.. (2025). Plain language summary: efficacy and safety of gepotidacin, a new oral antibiotic, compared with nitrofurantoin, a commonly used oral antibiotic, for treating uncomplicated urinary tract infection. Future Microbiology. 20(4). 265–275. 1 indexed citations

Wagenlehner, Flo ri an, Caroline Perry, Thomas M. Hooton, et al.. (2024). Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials. The Lancet. 403(10428). 741–755. 44 indexed citations breakdown →

Wagenlehner, Flo ri an, Caroline Perry, Thomas M. Hooton, et al.. (2023). P31 Efficacy and safety of oral gepotidacin in the treatment of uncomplicated urinary tract infection: results of two randomized, multicentre Phase 3 trials (EAGLE-2 and EAGLE-3). JAC-Antimicrobial Resistance. 5(Supplement_3). 2 indexed citations

Hooton, Thomas M., et al.. (2023). 2832. Gepotidacin Efficacy in E. coli Drug-Resistant Phenotypes: A Pooled Analysis of the EAGLE-2 and EAGLE-3 Randomized Controlled Trials in Uncomplicated Urinary Tract Infection. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

McCurdy, Sandra P., Amanda Sheets, Sue Cammarata, & Jorge E. Vidal. (2021). Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates from a Phase III community-acquired bacterial pneumonia (CABP) trial. JAC-Antimicrobial Resistance. 3(2). dlab057–dlab057. 5 indexed citations

McCurdy, Sandra P., et al.. (2020). Efficacy of delafloxacin versus moxifloxacin against atypical bacterial respiratory pathogens in adults with community-acquired bacterial pneumonia (CABP): Data from the Delafloxacin Phase 3 CABP Trial. International Journal of Infectious Diseases. 97. 374–379. 10 indexed citations

McCurdy, Sandra P., et al.. (2019). Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial. Antimicrobial Agents and Chemotherapy. 64(3). 29 indexed citations

10.

McCurdy, Sandra P., et al.. (2019). 2230. Analysis of the Microbiological Data from the Delafloxacin (DLX) Phase 3 Community-acquired Bacterial Pneumonia (CABP) Trial. Open Forum Infectious Diseases. 6(Supplement_2). S761–S762. 1 indexed citations

11.

Sheets, Amanda, et al.. (2018). 290. Safety and Effectiveness of Oral Sodium Fusidate (Fusidic Acid) as Chronic Antibiotic Suppressive Therapy in Patients With Staphylococcal Bone or Joint Infections. Open Forum Infectious Diseases. 5(suppl_1). S119–S119. 1 indexed citations

12.

File, Thomas M., Barbara Rewerska, Anita Das, et al.. (2016). SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia. Clinical Infectious Diseases. 63(8). 1007–1016. 58 indexed citations

13.

Oldach, David, Hristo Metev, Analía Mykietiuk, et al.. (2015). Characterization of Mycoplasma pneumoniae Infection and Outcomes in the SOLITAIRE-Oral, Global Phase 3 Clinical Trial for Solithromycin. Open Forum Infectious Diseases. 2(suppl_1). 2 indexed citations

14.

Scheller, Erich V., Jeffrey A. Melvin, Amanda Sheets, & Peggy A. Cotter. (2015). Cooperative Roles for Fimbria and Filamentous Hemagglutinin inBordetellaAdherence and Immune Modulation. mBio. 6(3). e00500–15. 24 indexed citations

15.

McCann, Jessica R., Amanda Sheets, Susan Grass, & Joseph W. St. Geme. (2014). The Haemophilus Cryptic Genospecies Cha Adhesin Has at Least Two Variants That Differ in Host Cell Binding, Bacterial Aggregation, and Biofilm Formation Properties. Journal of Bacteriology. 196(9). 1780–1788. 4 indexed citations

16.

Henderson, Michael W., Carol Inatsuka, Amanda Sheets, et al.. (2012). Contribution of Bordetella Filamentous Hemagglutinin and Adenylate Cyclase Toxin to Suppression and Evasion of Interleukin-17-Mediated Inflammation. Infection and Immunity. 80(6). 2061–2075. 44 indexed citations

17.

Sheets, Amanda & Joseph W. St. Geme. (2010). Adhesive Activity of the Haemophilus Cryptic Genospecies Cha Autotransporter Is Modulated by Variation in Tandem Peptide Repeats. Journal of Bacteriology. 193(2). 329–339. 22 indexed citations

18.

Sheets, Amanda, Susan Grass, Sara Miller, & Joseph W. St. Geme. (2008). Identification of a Novel Trimeric Autotransporter Adhesin in the Cryptic Genospecies of Haemophilus. Journal of Bacteriology. 190(12). 4313–4320. 13 indexed citations

19.

Sandborn, William J., Gillian Lawson, Amanda Sheets, et al.. (1997). A dose‐ranging pharmacokinetic study of nicotine tartrate following single‐dose delayed‐release oral and intravenous administration. Alimentary Pharmacology & Therapeutics. 11(5). 865–874. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact